rs587779388

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_001253852.3(AP4B1):​c.1160_1161del​(p.Thr387ArgfsTer30) variant causes a frameshift change. The variant allele was found at a frequency of 0.000111 in 1,609,850 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00011 ( 0 hom. )

Consequence

AP4B1
NM_001253852.3 frameshift

Scores

Not classified

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:16B:1

Conservation

PhyloP100: 6.69
Variant links:
Genes affected
AP4B1 (HGNC:572): (adaptor related protein complex 4 subunit beta 1) This gene encodes a subunit of a heterotetrameric adapter-like complex 4 that is involved in targeting proteins from the trans-Golgi network to the endosomal-lysosomal system. Mutations in this gene are associated with cerebral palsy spastic quadriplegic type 5 (CPSQ5) disorder. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
AP4B1-AS1 (HGNC:44114): (AP4B1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-113898754-CTG-C is Pathogenic according to our data. Variant chr1-113898754-CTG-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 156414.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-113898754-CTG-C is described in Lovd as [Pathogenic]. Variant chr1-113898754-CTG-C is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
AP4B1NM_001253852.3 linkuse as main transcriptc.1160_1161del p.Thr387ArgfsTer30 frameshift_variant 6/10 ENST00000369569.6
AP4B1-AS1NR_125965.1 linkuse as main transcriptn.536+767_536+768del intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
AP4B1ENST00000369569.6 linkuse as main transcriptc.1160_1161del p.Thr387ArgfsTer30 frameshift_variant 6/101 NM_001253852.3 P1Q9Y6B7-1
AP4B1-AS1ENST00000419536.1 linkuse as main transcriptn.368+767_368+768del intron_variant, non_coding_transcript_variant 2

Frequencies

GnomAD3 genomes
AF:
0.000138
AC:
21
AN:
152144
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000137
AC:
34
AN:
247490
Hom.:
0
AF XY:
0.000142
AC XY:
19
AN XY:
134086
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000695
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000238
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000108
AC:
157
AN:
1457706
Hom.:
0
AF XY:
0.000127
AC XY:
92
AN XY:
725356
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.000612
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000203
Gnomad4 NFE exome
AF:
0.000124
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.000138
AC:
21
AN:
152144
Hom.:
0
Cov.:
32
AF XY:
0.000175
AC XY:
13
AN XY:
74346
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00173
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000189
Gnomad4 NFE
AF:
0.000191
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000727
Hom.:
0
Bravo
AF:
0.0000907
EpiCase
AF:
0.000164
EpiControl
AF:
0.000178

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:16Benign:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 47 Pathogenic:8
Pathogenic, criteria provided, single submitterclinical testingCentre for Mendelian Genomics, University Medical Centre LjubljanaSep 04, 2019This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM2,PM3,PP5. This variant was detected in homozygous state. -
Pathogenic, criteria provided, single submitterclinical testingMGZ Medical Genetics CenterMay 03, 2022- -
Pathogenic, criteria provided, single submitterclinical testingParis Brain Institute, Inserm - ICM-- -
Pathogenic, no assertion criteria providedliterature onlyOMIMApr 30, 2014- -
Likely pathogenic, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Pathogenic, no assertion criteria providedresearchInstitute of Human Genetics, University Medical Center Hamburg-EppendorfJan 01, 2012In two siblings who presented with severe ID, absent speech, microcephaly, growth retardation, and progressive spastic tetraplegia we detected the novel homozygous 2 bp deletion c.1159_1160delCA in AP4B1; the mutation was present in the heterozygous state in both parents. The AP4B1-associated phenotype has previously been assigned to spastic paraplegia-47 (SPG47). -
Pathogenic, criteria provided, single submitterclinical testingVictorian Clinical Genetics Services, Murdoch Childrens Research InstituteFeb 02, 2022Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with spastic paraplegia 47 (MIM#614066). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v2) <0.01 for a recessive condition (37 heterozygotes, 0 homozygotes). (SP) 0701 - Many NMD predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (ClinVar). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported in multiple individuals with spastic paraplegia 47 (ClinVar, PMID: 29193663). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Pathogenic, criteria provided, single submitterclinical testingInvitaeJan 09, 2024This sequence change creates a premature translational stop signal (p.Thr387Argfs*30) in the AP4B1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AP4B1 are known to be pathogenic (PMID: 22290197, 24700674, 24781758). This variant is present in population databases (rs587779388, gnomAD 0.07%). This premature translational stop signal has been observed in individual(s) with AP4B1-related conditions (PMID: 24781758). ClinVar contains an entry for this variant (Variation ID: 156414). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:5
Pathogenic, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Pathogenic, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJan 28, 2021- -
Pathogenic, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Pathogenic, criteria provided, single submitterclinical testingGeneDxNov 10, 2023Observed in homozygous state in several unrelated patients in published literature with hypotonia, spastic paraplegia, microcephaly, severe intellectual disability, and global developmental delay and not observed in homozygous state in controls (PMID: 32166732, 24781758); Reported with a second AP4B1 variant in an individual with SPG47 in the published literature (PMID: 29193663); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 24781758, 21620353, 21440262, 22290197, 25552650, 25693842, 24700674, 19559397, 23167973, 20972249, 23472171, 31525725, 32166732, 31915823, 33728854, 32895917, 32964447, 33726816, 34544818, 34729478, 29193663) -
Pathogenic, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenApr 01, 2024AP4B1: PVS1, PM3:Strong, PM2 -
Spastic paraplegia Pathogenic:1
Likely pathogenic, no assertion criteria providedliterature onlyYale Center for Mendelian Genomics, Yale UniversityOct 01, 2020- -
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingAmbry GeneticsNov 30, 2016- -
Abnormality of the nervous system Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingKariminejad - Najmabadi Pathology & Genetics CenterJul 10, 2021- -
Intellectual disability Benign:1
Likely benign, no assertion criteria providedclinical testingCentre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de LilleJan 01, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs587779388; hg19: chr1-114441376; API